Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about LGVN
Recent news which mentions LGVN
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Longeveron's Alzheimer's Candidate Meets Safety Goal In Mid-Stage Study
October 05, 2023
Tickers
LGVN
Tags
why it's moving
General
Market News
From
Benzinga
Longeveron stock jumps on Alzheimer’s trial results
October 05, 2023
Tickers
LGVN
SPX
Tags
LGVN
SPX
From
MarketWatch
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
Tickers
AMTI
AVTX
IOVA
LGVN
Tags
YS
LGVN
Market News
From
Benzinga
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
September 14, 2023
Tickers
BCLI
BRTX
LGVN
Tags
BCLI
LGVN
Markets
From
Benzinga
Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market
September 11, 2023
Tickers
AMGN
LGVN
MRNA
Tags
LGVN
MRNA
Longeveron
From
Benzinga
Upcoming Phase 2 Data Expected For Longeveron's (NASDAQ: LGVN) Drug For the $4+ Billion Alzheimer's Sector – What To Look For
September 06, 2023
Tickers
ABOS
BIIB
LGVN
TLSA
Tags
Longeveron
LGVN
Market News
From
Benzinga
Why Lands' End Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
August 31, 2023
Tickers
ACER
AGIL
ALLR
ASO
Tags
LE
NCNC
HLTH
From
Benzinga
US Stocks Rise; Initial Jobless Claims Edge Lower
August 31, 2023
Tickers
ACER
AGIL
AXLA
LGVN
Tags
Penny Stocks
Trading Ideas
Earnings
From
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
August 31, 2023
Tickers
ACER
ALLR
APM
AXLA
Tags
BEAT
LGVN
ALLR
From
Benzinga
As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs
August 29, 2023
Tickers
ABBV
BRTX
LGVN
MESO
Tags
Benzinga
MESO
BRTX
From
Benzinga
Earnings Scheduled For August 11, 2023
August 11, 2023
Tickers
AC
ADN
AIM
AIRS
Tags
CWCO
Benzinga
SGBX
From
Benzinga
Earnings Preview: Longeveron
August 10, 2023
Tickers
LGVN
Tags
BZI/EP
LGVN
Earnings
From
Benzinga
Longeveron – This Biotech Company Is Using The Body's Own Cells To Fight Age-Related Diseases
August 07, 2023
Tickers
LGVN
Tags
Longeveron
LGVN
Market News
From
Benzinga
Longeveron Announces Key Additions To Its Leadership Team And Board As It Gears Up For Phase 2 Trials For Its Lead Drug Candidate For Several Conditions
August 07, 2023
Tickers
AMGN
LGVN
LLY
Tags
Biotech
Benzinga
Partner Content
From
Benzinga
Longeveron – Regenerative Medicine Developer Announces 100% Long Term Survival Rate For Children With HLHS
July 11, 2023
Tickers
LGVN
Tags
Market News
Longeveron
LGVN
From
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 07, 2023
Tickers
BJDX
CMRA
CSTL
CVKD
Tags
CSTL
CVKD
BZI/TFM
From
Benzinga
HLHS Is A Rare And Serious Congenital Heart Disease With A 33% Neonatal Death Rate — Could Longeveron's Lomecel-B Improve Outcomes?
June 28, 2023
Tickers
LGVN
Tags
Benzinga
Penny Stocks
Biotech
From
Benzinga
LGVN Stock Earnings: Longeveron Misses EPS, Revenue Estimates
May 12, 2023
Tickers
LGVN
Tags
Market News
LGVN
Top Stocks Portfolio
From
InvestorPlace
Earnings Scheduled For May 12, 2023
May 12, 2023
Tickers
AC
ACXP
ADAP
AGIL
Tags
IMPL
Benzinga
HMC
From
Benzinga
Recap: Longeveron Q1 Earnings
May 12, 2023
Tickers
LGVN
Tags
Market News
Benzinga
Earnings
From
Benzinga
Preview: Longeveron's Earnings
May 11, 2023
Tickers
LGVN
Tags
BZI/EP
Market News
LGVN
From
Benzinga
Longeveron's Lomecel-BTM Shows Encouraging Survival Data, Keeps Hypoplastic Left Heart Syndrome Pediatric Patients Heart Transplant-Free
May 09, 2023
Tickers
LGVN
Tags
Market News
LGVN
why it's moving
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Tickers
BLCM
CHRS
ENSC
ENTA
Tags
Market News
BLCM
LGVN
From
Benzinga
Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 09, 2023
Tickers
ALTO
APM
ARIS
ARKO
Tags
SHPW
MPLN
ENTA
From
Benzinga
Why Is Longeveron (LGVN) Stock Up 30% Today?
May 09, 2023
Tickers
FSR
LCID
LGVN
NKLA
Tags
Market News
LGVN
LCID
From
InvestorPlace
Longeveron Doses First Patient In Phase 2 Clinical Trial Of Lomecel-B™ In Japan For Aging-Related Frailty
April 20, 2023
Tickers
LGVN
Tags
M&A
Market News
Longeveron
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 21, 2023
Tickers
ACDC
ADCT
ADMP
AG
Tags
AMV
CSR
SMX
From
Benzinga
Earnings Scheduled For March 10, 2023
March 10, 2023
Tickers
AIRS
BKE
BRDS
CCLP
Tags
SUNW
TH
SDPI
From
Benzinga
Insiders Just Bought $1 Million of This Deep Value Tech Stock
March 07, 2023
Tickers
AAPL
CMLS
IHRT
LGVN
Tags
NFLX
MSFT
IHRT
From
InvestorPlace
3 Penny Stocks That Could Rise 500% in 2023
January 13, 2023
Tickers
BZH
CEIX
DBD
DNA
Tags
Market News
LGVN
DNA
From
InvestorPlace
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.